Xiumei Wu
Biographic Data
| ID | 7258316 |
|---|---|
| NAME | Xiumei Wu |
| GIVEN NAMES | Xiumei |
| FAMILY NAME | Wu |
| SIGNATURE | WU X |
| AFFILIATIONS | Zhejiang Hisun Pharmaceutical (China) |
| ORCID | 0009-0004-2246-1307 |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Influence of symptom burden on social alienation in lung cancer patients receiving chemotherapy
The impact of symptom burden on social alienation is moderated through PSS and PPC, manifesting both directly and indirectly. Moreover, the influence of PPC tends to mitigate the mediating role of PSS. Clinical interventions aimed at bolstering PSS and augmenting PPC may potentially alleviate social alienation and enhance the quality of life for patients undergoing chemotherapy for LC
Effect of Laggera alata on hepatocyte damage induced by carbon tetrachloride in vitro and in vivo
Effect of total phenolics from Laggera alata on acute and chronic inflammation models
No prominent works on this page.
Effect of total phenolics from Laggera alata on acute and chronic inflammation models
Effect of Laggera alata on hepatocyte damage induced by carbon tetrachloride in vitro and in vivo
Influence of symptom burden on social alienation in lung cancer patients receiving chemotherapy
The impact of symptom burden on social alienation is moderated through PSS and PPC, manifesting both directly and indirectly. Moreover, the influence of PPC tends to mitigate the mediating role of PSS. Clinical interventions aimed at bolstering PSS and augmenting PPC may potentially alleviate social alienation and enhance the quality of life for patients undergoing chemotherapy for LC
Internal Medicine (3 works) · Medicine (3 works) · Biochemistry (2 works) · Chemistry (2 works) · Enzyme (2 works) · Glutathione (2 works) · Pharmacology (2 works) · Acute toxicity (1 works) · Alanine transaminase (1 works) · Albumin (1 works)